Literature DB >> 10417615

Protein C inhibitor is expressed in keratinocytes of human skin.

M Krebs1, P Uhrin, A Vales, M J Prendes-Garcia, J Wojta, M Geiger, B R Binder.   

Abstract

Protein C inhibitor is a member of the serpin family that inhibits a variety of serine proteases. Protein C inhibitor is present in numerous body fluids and is produced in the liver and by various epithelial cells. To determine if this epithelial serpin is present in skin, immunohistochemical studies were performed that showed strong staining for protein C inhibitor antigen in the epidermis. Protein C inhibitor mRNA was detected in the keratinocyte cell line HaCaT and the epidermoid carcinoma cell line A431 using reverse transcription-polymerase chain reaction suggesting that also in normal skin protein C inhibitor is derived from keratinocytes. Conditioned media from these cell lines were analyzed on immunoblots, which revealed a protein C inhibitor-antigen band that comigrated with protein C inhibitor derived from the hepatoma cell line HepG2. Using an enzyme-linked immunosorbent assay specific for total protein C inhibitor antigen the accumulation of protein C inhibitor in the cell culture supernatants of HaCaT keratinocytes was found to be 0.3 ng per h per 1 million cells. This is similar to the amount of plasminogen activator inhibitor-1 produced by these cells, which also produce tissue plasminogen activator and urokinase. Fluorescence-activated cell sorter analysis revealed similar expression of intracellular protein C inhibitor antigen in proliferating and confluent HaCaT cells. These findings demonstrate that protein C inhibitor antigen is present in the normal epidermis and that protein C inhibitor is constitutively expressed by keratinocytes in culture. Therefore, protein C inhibitor may provide protease inhibitory activity not only to internal, but also to the external surface of the body. Additionally, protein C inhibitor could contribute to the regulation of retinoid supply in the epidermis, as we have shown recently that retinoic acid binds specifically to protein C inhibitor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417615     DOI: 10.1046/j.1523-1747.1999.00644.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Early gene changes induced by isotretinoin in the skin provide clues to its mechanism of action.

Authors:  Amanda M Nelson; Wei Zhao; Kathryn L Gilliland; Andrea L Zaenglein; Wenlei Liu; Diane M Thiboutot
Journal:  Dermatoendocrinol       Date:  2009-03

2.  Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN.

Authors:  Gary F Clark; Paola Grassi; Poh-Choo Pang; Maria Panico; David Lafrenz; Erma Z Drobnis; Michael R Baldwin; Howard R Morris; Stuart M Haslam; Sophia Schedin-Weiss; Wei Sun; Anne Dell
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

Review 3.  Activated protein C: A regulator of human skin epidermal keratinocyte function.

Authors:  Kelly McKelvey; Christopher John Jackson; Meilang Xue
Journal:  World J Biol Chem       Date:  2014-05-26

4.  Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility.

Authors:  P Uhrin; M Dewerchin; M Hilpert; P Chrenek; C Schöfer; M Zechmeister-Machhart; G Krönke; A Vales; P Carmeliet; B R Binder; M Geiger
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

5.  Expression patterns of protein C inhibitor in mouse development.

Authors:  Gerry T M Wagenaar; Pavel Uhrin; Klara Weipoltshammer; Marlene Almeder; Pieter S Hiemstra; Margarethe Geiger; Joost C M Meijers; Christian Schöfer
Journal:  J Mol Histol       Date:  2010-03-14       Impact factor: 2.611

6.  Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase.

Authors:  Thomas A Prohaska; Felix C Wahlmüller; Margareta Furtmüller; Margarethe Geiger
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.